At the Healthcare Packaging Expo, being held 14–17 October in Chicago, Herma US will be located at Booth W-838
Herma, a Germany-based provider of labelling machinery and self-adhesive labels and materials for the global packaging marketplace – will showcase new features for several of its popular labelling machines at Healthcare Packaging Expo, 14–17 October in Chicago. Herma US will be located at Booth W-838.
First, Herma will showcase its Herma 362 E TE tamper evident labelling system. Derived from the proven Herma 362E front/back labelling system, the 362 E TE can apply one or two tamper-evident labels to a wide range of cartons. Tamper-evident labels are a legal requirement forming a vital component in product security for pharmaceutical cartons.
Capable of achieving speeds of more than 200 cartons per minute, the Herma 362E TE can be installed with a TIJ or laser coders, as well as a wide range of track and trace systems to produce fully serialised and inspected cartons.
Herma US also will be touting a higher-speed, motion control version of its Herma 132M Wrap-around Labeler, which is now available at expedited speeds of 400 products per minute. The turret-based machine features a rotating star wheel for precise product transport. It can be outfitted with a wide range of printing and vision systems, and features automatic rejection of out-of-specification labels before they are applied.
Herma US will also showcase its 152E Wraparound Labeler, which features the same heavy-duty label applicator platform as the company’s premium “M” (Master) series, allowing for simple installation of printers and vision systems. The module can handle substrate diameters from ½” to 4” at speeds of up to 150 products per minute, and can be fitted with either an Allen-Bradley or Siemens PLC controller.
“By adding new features to our existing line of machinery, HERMA continues to emphasize innovation and functionality,” said Peter Goff, CEO of Herma US. “These capabilities will ensure continuous success in packaging lines in major pharmaceutical companies here in North America and worldwide.”